Anti-CD44 Immunotherapy in Arthritis

Mikecz, Katalin None

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Type: Research Project (R01)
• Project #: 1R01AR044126-01
• Application #: 2083850
• Study Section: Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
• Project Start: 1996-04-01
• Project End: 1999-03-31
• Budget Start: 1996-04-01
• Budget End: 1997-03-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Rush University Medical Center
• City: Chicago
• State: IL
• Country: United States
• Zip Code: 60612

Publications

Kim, J H; Glant, T T; Lesley, J et al. (2000) Adhesion of lymphoid cells to CD44-specific substrata: the consequences of attachment depend on the ligand. Exp Cell Res 256:445-53

Mikecz, K; Dennis, K; Shi, M et al. (1999) Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 42:659-68

Glant, T T; Cs-Szabo, G; Nagase, H et al. (1998) Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum 41:1007-18

Glant, T T; Buzas, E I; Finnegan, A et al. (1998) Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 160:3812-9